Healthequity Inc (HQY) Expected to Announce Quarterly Sales of $58.51 Million

Equities research analysts expect that Healthequity Inc (NASDAQ:HQY) will post sales of $58.51 million for the current quarter, according to Zacks Investment Research. Eight analysts have provided estimates for Healthequity’s earnings. The highest sales estimate is $59.30 million and the lowest is $57.38 million. Healthequity reported sales of $46.81 million in the same quarter last year, which indicates a positive year-over-year growth rate of 25%. The company is scheduled to issue its next quarterly earnings results on Tuesday, March 20th.

According to Zacks, analysts expect that Healthequity will report full-year sales of $58.51 million for the current year, with estimates ranging from $226.46 million to $228.40 million. For the next year, analysts forecast that the business will report sales of $278.89 million per share, with estimates ranging from $272.92 million to $283.90 million. Zacks’ sales averages are an average based on a survey of sell-side research firms that follow Healthequity.

Healthequity (NASDAQ:HQY) last announced its earnings results on Tuesday, December 5th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.13 by $0.04. Healthequity had a net margin of 21.08% and a return on equity of 14.47%. The company had revenue of $56.80 million during the quarter, compared to analyst estimates of $55.27 million. During the same period in the previous year, the business earned $0.10 earnings per share. The firm’s quarterly revenue was up 31.0% compared to the same quarter last year.

HQY has been the subject of several research reports. Cantor Fitzgerald reiterated a “buy” rating and issued a $56.00 target price on shares of Healthequity in a research report on Monday, September 25th. Citigroup began coverage on shares of Healthequity in a research report on Thursday, January 4th. They set a “buy” rating for the company. Zacks Investment Research upgraded shares of Healthequity from a “hold” rating to a “buy” rating and set a $60.00 price target for the company in a research report on Wednesday, November 8th. Chardan Capital upped their price target on shares of Healthequity from $58.00 to $62.00 and gave the company a “buy” rating in a research report on Wednesday, December 6th. Finally, BidaskClub upgraded shares of Healthequity from a “sell” rating to a “hold” rating in a research report on Thursday, September 28th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. Healthequity presently has an average rating of “Buy” and a consensus price target of $58.33.

In other news, Director Frank Medici sold 419,504 shares of the company’s stock in a transaction dated Monday, November 6th. The shares were sold at an average price of $52.97, for a total transaction of $22,221,126.88. Following the completion of the transaction, the director now directly owns 6,381 shares of the company’s stock, valued at $338,001.57. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, major shareholder Berkley Capital, Llc sold 13,600 shares of the company’s stock in a transaction dated Thursday, November 2nd. The shares were sold at an average price of $51.02, for a total transaction of $693,872.00. Following the transaction, the insider now directly owns 6,381 shares of the company’s stock, valued at $325,558.62. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 1,106,934 shares of company stock valued at $57,943,828. Company insiders own 29.00% of the company’s stock.

Several large investors have recently modified their holdings of the company. BlackRock Inc. raised its stake in Healthequity by 4.3% in the second quarter. BlackRock Inc. now owns 5,831,014 shares of the company’s stock worth $290,559,000 after buying an additional 241,061 shares in the last quarter. Vanguard Group Inc. raised its stake in Healthequity by 3.0% in the second quarter. Vanguard Group Inc. now owns 4,237,298 shares of the company’s stock worth $211,145,000 after buying an additional 122,061 shares in the last quarter. Wasatch Advisors Inc. raised its stake in Healthequity by 2.2% in the second quarter. Wasatch Advisors Inc. now owns 2,442,180 shares of the company’s stock worth $121,694,000 after buying an additional 52,885 shares in the last quarter. FMR LLC raised its stake in Healthequity by 45.6% in the second quarter. FMR LLC now owns 2,235,150 shares of the company’s stock worth $111,378,000 after buying an additional 699,728 shares in the last quarter. Finally, Janus Henderson Group PLC raised its stake in Healthequity by 627.9% in the second quarter. Janus Henderson Group PLC now owns 2,113,030 shares of the company’s stock worth $105,292,000 after buying an additional 1,822,732 shares in the last quarter. 98.25% of the stock is owned by hedge funds and other institutional investors.

Shares of Healthequity (NASDAQ:HQY) traded down $0.19 during trading hours on Friday, reaching $48.21. 448,073 shares of the company traded hands, compared to its average volume of 595,347. Healthequity has a one year low of $37.62 and a one year high of $55.31. The stock has a market capitalization of $2,930.00, a price-to-earnings ratio of 65.15, a PEG ratio of 1.99 and a beta of 1.74.

TRADEMARK VIOLATION WARNING: “Healthequity Inc (HQY) Expected to Announce Quarterly Sales of $58.51 Million” was first published by American Banking News and is the sole property of of American Banking News. If you are reading this news story on another publication, it was copied illegally and reposted in violation of United States & international copyright and trademark laws. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2018/01/21/healthequity-inc-hqy-expected-to-announce-quarterly-sales-of-58-51-million.html.

About Healthequity

HealthEquity, Inc provides a range of solutions for managing healthcare accounts (Health Savings Accounts (HSAs), Health Reimbursement Arrangements (HRAs) and Flexible Spending Accounts (FSAs)) for health plans, insurance companies and third-party administrators. The Company is engaged in technology-enabled services platforms that allow consumers to make healthcare saving and spending decisions.

Get a free copy of the Zacks research report on Healthequity (HQY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Healthequity (NASDAQ:HQY)

Receive News & Ratings for Healthequity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Healthequity and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply